Bank of America Corp DE trimmed its stake in shares of Semler Scientific Inc. (NASDAQ:SMLR - Free Report) by 84.0% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 5,231 shares of the company's stock after selling 27,407 shares during the period. Bank of America Corp DE owned 0.06% of Semler Scientific worth $282,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently bought and sold shares of the company. BNP Paribas Financial Markets bought a new position in shares of Semler Scientific during the 4th quarter valued at approximately $30,000. Jones Financial Companies Lllp purchased a new stake in Semler Scientific during the fourth quarter valued at $34,000. Larson Financial Group LLC bought a new position in Semler Scientific during the fourth quarter valued at $38,000. NewEdge Advisors LLC lifted its position in Semler Scientific by 318.3% during the fourth quarter. NewEdge Advisors LLC now owns 732 shares of the company's stock valued at $40,000 after purchasing an additional 557 shares during the last quarter. Finally, IFP Advisors Inc purchased a new position in shares of Semler Scientific in the 4th quarter worth $54,000. 49.37% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen cut shares of Semler Scientific from a "buy" rating to a "sell" rating in a research report on Thursday, May 22nd.
View Our Latest Stock Report on SMLR
Semler Scientific Trading Down 6.5%
Shares of NASDAQ:SMLR traded down $1.99 during trading on Tuesday, hitting $28.53. The company had a trading volume of 1,042,517 shares, compared to its average volume of 512,556. The stock has a market cap of $318.11 million, a price-to-earnings ratio of -10.93 and a beta of 1.42. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.52 and a quick ratio of 0.51. The company has a fifty day simple moving average of $35.40 and a two-hundred day simple moving average of $45.09. Semler Scientific Inc. has a one year low of $21.77 and a one year high of $81.56.
Semler Scientific (NASDAQ:SMLR - Get Free Report) last issued its quarterly earnings results on Tuesday, May 13th. The company reported ($0.76) earnings per share (EPS) for the quarter. The company had revenue of $8.84 million during the quarter. Semler Scientific had a positive return on equity of 19.75% and a negative net margin of 60.69%.
Semler Scientific Profile
(
Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Further Reading

Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.